首页|安保利托君与硫酸镁治疗胎膜早破型先兆早产的疗效比较

安保利托君与硫酸镁治疗胎膜早破型先兆早产的疗效比较

Baoli asked Jun and compare the efficacy of magnesium sulfate treatment of preterm premature rupture of Threatened

扫码查看
目的:分析比较安保利托君与硫酸镁治疗胎膜早破型先兆早产的临床疗效。方法:选取98例胎膜早破型先兆早产患者为研究对象,采用数字表法随机分为观察组与对照组各49例,观察组给予安保利托君治疗,对照组给予硫酸镁治疗。结果:观察组治疗总有效率(93.88%)、孕周延长时间(20.2±1.8)d、保胎成功率(89.80%)、新生儿出生体质量(2716.0±282.0)kg、新生儿出生Apgar评分(9.4±0.6)分明显高于对照组;治疗后显效时间(50.6±7.5)min明显快于对照组,不良反应率(6.12%)明显低于对照组( P<0.01,P<0.05)。结论:利托君治疗胎膜早破型先兆早产可有效缩短宫缩时间、延长孕龄,提高新生儿体质量及存活率,且不良反应低,值得临床推广。
Objective: To compare the Baoli care monarch and clinical efficacy of magnesium sulfate treatment of threatened preterm premature rupture of membrane type. Methods:98 cases of patients with threatened preterm PROM type for the study, using a random number table is divided into observation group and control group of 49 patients in the observation group asked the king to give Baoli treatment, the control group received magnesium sulfate therapy. Results: The total effective rate (93.88%), prolonged gestation period (20.2 ± 1.8) d, miscarriage success rate (89.80%), neonatal birth weight (2716.0 ± 282.0) kg, neonatal Apgar score (9.4 ± 0.6) points significantly higher; markedly after treatment time (50.6 ± 7.5) min significantly faster than the control group, adverse reaction rates (6.12%) was significantly lower than the control group (P <0.01, P <0.05) . Conclusion:Treatment Ritodrine Threatened preterm rupture of membranes can effectively shorten the time contractions, prolonged gestational age, body mass and improve neonatal survival, and low adverse reaction, worthy of promotion.

ritodrinemagnesiumrupture of membranesthreatened premature

胡晓丽

展开 >

山东省临沂市妇幼保健院 276000

利托君 硫酸镁 胎膜早破 先兆早产

2014

中外健康文摘
中国中医药报社

中外健康文摘

影响因子:0.016
ISSN:1672-5085
年,卷(期):2014.(21)
  • 4